{"id":400884,"date":"2020-12-16T08:33:33","date_gmt":"2020-12-16T13:33:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400884"},"modified":"2020-12-16T08:33:33","modified_gmt":"2020-12-16T13:33:33","slug":"myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/","title":{"rendered":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BASEL, Switzerland, Dec.  16, 2020  (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards for 46 new employees with a grant date of December 15, 2020 pursuant to Myovant\u2019s 2020 Inducement Plan. The equity awards were granted to the employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08.<\/p>\n<p>The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 126,800 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, subject to each such employee\u2019s continued employment with Myovant on such vesting dates. The RSUs are subject to the terms and conditions of the 2020 Inducement Plan and the applicable restricted stock unit agreements.<\/p>\n<p>\n        <strong>About Myovant Sciences<\/strong><br \/>\n        <br \/>Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our lead product candidate, relugolix, is a once-daily, oral GnRH receptor antagonist. Relugolix monotherapy tablet (120 mg) is under regulatory review in the U.S. for men with advanced prostate cancer. Relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis. We are also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is our majority shareholder. For more information, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4tQaaaMkCifLVti-HGowDgh9M0ug_ARgQOBwMIg0T7yUlhGNTY9yp9mCPa28KepCNEKGGUDgjXRjJO0FhFFoUw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.myovant.com<\/a>. Follow <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kJeJpgOv6_Xg5i4uLoy_dCrg9f8fXfF2BXAJCKd-GzI7D63mnudhDCI2Q9JWS1kiN6QtIZExfOj93AKdFZW3Hg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">@Myovant<\/a> on Twitter and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mrpzb652idhZk9cRjpiTuyE0CyEETHfU9wZ27NhExzsTwB4PvCwpAmipT0Rs9Xt2h7wpf9pVSXfdHABkSai2GCns0zpCC4GFY6AdWbuIqRM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Ryan Crowe<br \/>Vice President, Investor Relations<br \/>Myovant Sciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jh0-yNQsdDYgqd1xfsi4yXCNA_XCg4UXdZk8HYkjPt-BcG1pXc1FMu1EZ_kYHkon7wbO91vCEAFBGU6mddeTrejo06wrMYKSIQPbC7N-BtM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@myovant.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Albert Liao<br \/>Director, Corporate Communications<br \/>Myovant Sciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rE8pMmzww-7TA4f02mTwwCYkr_vwYyBeAivU-qYEgvcHrpAUEUrVYTi5GjXVkqTNSjOZFrLas8jLP2f-5u36xA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">media@myovant.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/31249754-b259-4913-bcff-7590bd95070d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASEL, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards for 46 new employees with a grant date of December 15, 2020 pursuant to Myovant\u2019s 2020 Inducement Plan. The equity awards were granted to the employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08. The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 126,800 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-400884","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASEL, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards for 46 new employees with a grant date of December 15, 2020 pursuant to Myovant\u2019s 2020 Inducement Plan. The equity awards were granted to the employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08. The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 126,800 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, &hellip; Continue reading &quot;Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T13:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\",\"datePublished\":\"2020-12-16T13:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/\",\"name\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\",\"datePublished\":\"2020-12-16T13:33:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/","og_locale":"en_US","og_type":"article","og_title":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","og_description":"BASEL, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards for 46 new employees with a grant date of December 15, 2020 pursuant to Myovant\u2019s 2020 Inducement Plan. The equity awards were granted to the employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08. The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 126,800 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, &hellip; Continue reading \"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T13:33:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08","datePublished":"2020-12-16T13:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/"},"wordCount":330,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/","name":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=","datePublished":"2020-12-16T13:33:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjk0NSMzODgzNDYyIzIxNzcyNDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=400884"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400884\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=400884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=400884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=400884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}